The Valley Desk

Clinical trial reportMovement disorders : official journal of the Movement Disorder SocietyPublished

A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Cooper Medical School of Rowan University, with Rowan University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Movement disorders : official journal of the Movement Disorder Society
Published
Subject terms
Humans; Parkinson Disease; Indans; Antiparkinson Agents; Double-Blind Method; Benzothiazoles; Sleepiness; Pramipexole; Parkinson's Disease; Rasagiline; P2b001
PubMed ID
37886872
Added to directory
Source checked

Report a correction or request removal